These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 16825091

  • 1. Long-term management of sevelamer hydrochloride-induced metabolic acidosis aggravation and hyperkalemia in hemodialysis patients.
    Sonikian M, Metaxaki P, Iliopoulos A, Marioli S, Vlassopoulos D.
    Ren Fail; 2006; 28(5):411-8. PubMed ID: 16825091
    [Abstract] [Full Text] [Related]

  • 2. Sevelamer worsens metabolic acidosis in hemodialysis patients.
    De Santo NG, Frangiosa A, Anastasio P, Marino A, Correale G, Perna A, Di Stazio E, Stellato D, Santoro D, Di Meglio E, Iacono G, Ciacci C, Savica V, Cirillo M.
    J Nephrol; 2006; 19 Suppl 9():S108-14. PubMed ID: 16736432
    [Abstract] [Full Text] [Related]

  • 3. Metabolic acidosis aggravation and hyperkaliemia in hemodialysis patients treated by sevelamer hydrochloride.
    Sonikian MA, Pani IT, Iliopoulos AN, Koutala KG, Marioli SI, Vlassopoulos DA.
    Ren Fail; 2005; 27(2):143-7. PubMed ID: 15807177
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (RenaGel) in dialysis patients.
    Wilkes BM, Reiner D, Kern M, Burke S.
    Clin Nephrol; 1998 Dec; 50(6):381-6. PubMed ID: 9877112
    [Abstract] [Full Text] [Related]

  • 5. Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage.
    Oka Y, Miyazaki M, Takatsu S, Kunitomo K, Uno F, Maruyama M, Matsuda H.
    Ther Apher Dial; 2007 Apr; 11(2):107-13. PubMed ID: 17381531
    [Abstract] [Full Text] [Related]

  • 6. Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines.
    Izumi M, Shirai K, Ito K, Miyamoto T, Matsumoto A, Takenaka Y, Nakagawa K, Yamanashi T, Takamitsu Y, Nakanish T.
    Ther Apher Dial; 2005 Feb; 9(1):24-31. PubMed ID: 15828902
    [Abstract] [Full Text] [Related]

  • 7. Lanthanum carbonate versus sevelamer hydrochloride: improvement of metabolic acidosis and hyperkalemia in hemodialysis patients.
    Filiopoulos V, Koutis I, Trompouki S, Hadjiyannakos D, Lazarou D, Vlassopoulos D.
    Ther Apher Dial; 2011 Feb; 15(1):20-7. PubMed ID: 21272248
    [Abstract] [Full Text] [Related]

  • 8. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C, Savidaki E, Roumelioti M, Dousdampanis P, Hardalias A, Kalliakmani P, Papachristou E, Drakopoulos A, Goumenos DS, Vlachojannis JG.
    Adv Perit Dial; 2006 Feb; 22():187-91. PubMed ID: 16983967
    [Abstract] [Full Text] [Related]

  • 9. Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications.
    Pai AB, Shepler BM.
    Pharmacotherapy; 2009 May; 29(5):554-61. PubMed ID: 19397463
    [Abstract] [Full Text] [Related]

  • 10. Different routes bridging calcium in Japanese hemodialysis patients.
    Hamano T, Fujii N, Ito T, Imai E.
    Ther Apher Dial; 2005 Feb; 9(1):32-8. PubMed ID: 15828903
    [Abstract] [Full Text] [Related]

  • 11. Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
    Kokuho T, Toya Y, Kawaguchi Y, Tamura K, Iwatsubo K, Dobashi Y, Nakazawa A, Takeda H, Iwatsubo M, Hirawa N, Yasuda G, Ohnishi T, Umemura S.
    Ther Apher Dial; 2007 Dec; 11(6):442-8. PubMed ID: 18028171
    [Abstract] [Full Text] [Related]

  • 12. Peritoneal dialysis patients using sevelamer do not present the acidosis problems that hemodialysis patients do.
    Pagé D, Knoll G.
    Adv Perit Dial; 2005 Dec; 21():185-7. PubMed ID: 16686315
    [Abstract] [Full Text] [Related]

  • 13. Sevelamer hydrochloride dose-dependent increase in prevalence of severe acidosis in hemodialysis patients: analysis of nationwide statistical survey in Japan.
    Oka Y, Miyazaki M, Matsuda H, Takatsu S, Katsube R, Mori T, Takehara K, Umeda Y, Uno F.
    Ther Apher Dial; 2014 Feb; 18(1):37-43. PubMed ID: 24499082
    [Abstract] [Full Text] [Related]

  • 14. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.
    Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, Scolari F, Cancarini GC, Maiorca R.
    Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761
    [Abstract] [Full Text] [Related]

  • 15. Chronic acid-base perturbations in hemodialysis patients treated with sevelamer hydrochloride: a two-year follow-up study.
    Vlahakos DV, Retsa K, Kalogeropoulou S, Katsoudas S, Bacharaki D, Agroyannis B.
    Artif Organs; 2007 Dec; 31(12):892-5. PubMed ID: 17924988
    [Abstract] [Full Text] [Related]

  • 16. Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients on sevelamer hydrochloride: which dialysate calcium concentration to use?
    Sonikian M, Metaxaki P, Karatzas I, Vlassopoulos D.
    Blood Purif; 2009 Dec; 27(2):182-6. PubMed ID: 19141997
    [Abstract] [Full Text] [Related]

  • 17. Influence of sevelamer on mineral metabolism and hyperparathyroidism in Japanese hemodialysis patients.
    Inoue T, Nagatoya K, Kagitani M, Shibahara N, Ueda H, Katsuoka Y, Ohashi S, Kitagawa Y, Nishimoto K, Yasuda H, Hokusetsu Renal Osteodystrophy Study Group.
    Ther Apher Dial; 2007 Jun; 11(3):210-4. PubMed ID: 17498003
    [Abstract] [Full Text] [Related]

  • 18. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M, McIntyre CW.
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [Abstract] [Full Text] [Related]

  • 19. Phosphate binder therapy for attainment of K/DOQI bone metabolism guidelines.
    Nolan CR.
    Kidney Int Suppl; 2005 Jul; (96):S7-14. PubMed ID: 15954948
    [Abstract] [Full Text] [Related]

  • 20. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
    Hwang JC, Chen CA, Wang CT, Chen HC.
    Ren Fail; 2008 Jul; 30(10):943-51. PubMed ID: 19016144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.